Holen Sie sich die Stockscreener-App
0.288
6.19%
0.0168
Handel nachbörslich:
.28
-0.008
-2.78%
Schlusskurs vom Vortag:
$0.2712
Offen:
$0.27
24-Stunden-Volumen:
1.79M
Relative Volume:
7.29
Marktkapitalisierung:
$1.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.74M
KGV:
-0.90
EPS:
-0.32
Netto-Cashflow:
$-8.25M
1W Leistung:
-79.57%
1M Leistung:
-86.79%
6M Leistung:
-88.48%
1J Leistung:
-62.48%
1-Tages-Spanne:
$0.2524
$0.3129
1-Wochen-Bereich:
$0.2524
$1.79
52-Wochen-Spanne:
$0.2524
$4.95
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| GCTK | 0.288 | 1.55M | 0 | -8.74M | -8.25M | -0.32 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11% - MSN
GlucoTrack Inc. (GCTK) Quarterly 10-Q Report - Quartzy
GlucoTrack Completes Funding to Enhance Financial Stability - TipRanks
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - The Manila Times
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - The Manila Times
Glucotrack Secures $10M Through Public Offering, Converts $4M Debt to Equity | GCTK Stock News - StockTitan
STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com
Glucotrack announces $10 million public offering By Investing.com - Investing.com Canada
GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com Australia
S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results - Benzinga
Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings - Benzinga
U.S. Stock market: Syros Pharmaceuticals(−86.21%), GlucoTrack(−77.70%) and others among the most volatile stocks during mid day trading - Business Upturn
U.S. Stock market: Syros Pharmaceuticals surges by 680.00% while Spirit Airlines rises by 184.96% in early trading - Business Upturn
US Stocks Mixed; Inflation Rate Increases In October - Benzinga
GlucoTrack prices 7.2M shares at $1.39 in public offering - TipRanks
Glucotrack announces pricing of $10M public offering - MSN
Glucotrack announces $10 million public offering - Investing.com
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering - The Manila Times
Fogo de Chão Launches Pro-Athlete 'Meat & Greet” Event Series With National Sports Teams - The Manila Times
Glucotrack (GCTK) Launches $10M Public Offering, Plans Note Conversion Deal | GCTK Stock News - StockTitan
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.66% - MSN
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.67% - MSN
GlucoTrack (NASDAQ:GCTK) to Present Continuous Blood Glucose Monitor at 2024 BioFuture Meeting** - Defense World
Say Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is Here - MSN
GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture - TipRanks
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - The Manila Times
GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 - MSN
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.4% – Here’s What Happened - Defense World
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology - Nasdaq
GlucoTrack Showcases Innovations at Diabetes Tech Meeting - TipRanks
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING - EIN News
Glucotrack shareholders approve pivotal issuance proposal - Investing.com India
Glucotrack shareholders approve pivotal issuance proposal By Investing.com - Investing.com Canada
Hand-held Glucose Meter Market Growth Ourlook – OrbisResearch - Economica
Godolphin Resources Unveils Comprehensive 2024 Annual Report - TipRanks
Globavend Holdings Limited Announces First Half 2024 Unaudited Financial Results - GlobeNewswire
Global Petroleum Expands Australian Exploration - TipRanks
Qwic owner EcoMotion saves cycling gear brand AGU from downfall - Bike Europe
GPT Infraprojects Secures ₹204 Crore Railway Contract - Indiainfoline
Local Winter Classic competitors clash again in SA Oaks final - The Border Watch
Greenlane to distribute new drug detection strips - Investing.com
GyC hits Kenya, South Africa, Mozambique for mega tour - Guardian Nigeria
Glucotrack Appoints Andy Balo To Its Board Of Directors - MPO-mag
Glucotrack Makes Two Senior Appointments - MPO-mag
Glucotrack appoints biotech veteran to board amid expansion By Investing.com - Investing.com Canada
Glucotrack appoints biotech veteran to board amid expansion - Investing.com
GlucoTrack appoints John Ballantyne to board of directors - TipRanks
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):